Shares of Edwards Lifesciences Corp. /zigman2/quotes/205745196/composite EW -2.92% inched 0.26% higher to $122.26 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -1.53% rising 0.28% to 4,726.35 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -1.30% rising 0.11% to 36,290.32. This was the stock's second consecutive day of gains. Edwards Lifesciences Corp. closed $9.47 short of its 52-week high ($131.73), which the company achieved on December 30th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Medtronic PLC /zigman2/quotes/206816578/composite MDT -1.06% rose 0.98% to $108.95, Boston Scientific Corp. /zigman2/quotes/203726728/composite BSX -1.97% rose 2.33% to $44.41, and ICU Medical Inc. /zigman2/quotes/208026181/composite ICUI -0.43% fell 2.53% to $229.46. Trading volume (2.0 M) remained 331,034 below its 50-day average volume of 2.3 M.